MALT1 inhibitors (Medical Research Council Technology/University of Lausanne)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMALT1 inhibitors (Medical Research Council Technology/University of Lausanne)
Drug Alias NameMALT1 inhibitors (MRCT/University of Lausanne)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetastasis Associated Lung Adenocarcinoma Transcript 1 inhibitors
TargetsMetastasis Associated Lung Adenocarcinoma Transcript 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLifearc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearcUniversity Of Lausanne
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A